Your SlideShare is downloading. ×
Plantibodies
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Plantibodies

3,315
views

Published on

Published in: Education, Technology

0 Comments
3 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
3,315
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
230
Comments
0
Likes
3
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. PLANTIBODIES :UNRAVELLING THE MYSTERY PRIYANKA PARKAR ROLL NO:23
  • 2. WHAT ARE PLANTIBODIES?A plantibody is an antibody produced bygenetically modified plants.Antibodies are part of animal immunesystems, and are produced in plants bytransforming them with antibody genesfrom animals.This was first done in 1989, with amouse antibody made by tobacco plants.Although plants do not naturally makeantibodies, plantibodies have beenshown to function in the same way asnormal antibodies.The term plantibody as well as theconcept is trademarked by the companyBiolex.
  • 3. ANTIBODY FACTORIES Plants are being used as antibody factories, using their endomembrane and secretory systems to produce large amounts of clinically viable proteins. Antibodies can be expressed in plants as either full-length molecules or as smaller fragments. Antibodies are produced in plants for both humans therapeutic purposes and for protection for plants against diseases.
  • 4. Full-size monoclonal antibodies recently produced in transgenic plants PLANT ANTIBODY TYPE (TARGET) PURPOSETOBACCO IgG (NEMATODE) Plant pathogen resistanceTOBACCO sIgG/A (steptococcus Therapeutic (topical) mutans)SOYABEAN, RICE IgG ( herpes simplex virus) Therapeutic (topical)TOBACCO IgG (colon cancer) Therapeutic (systemic injection)ALFALFA IgG ( human IgG) DiagnosticTOBACCO IgG (rabies virus) Therapeutic (systemic injection)TOBACCO IgG (hepatitis B virus) TherapeuticTOBACCO IgG ( low mol. wt. Catalytic antibodies phosphonate ester)
  • 5. METHODS FOR PLANTIBODY PRODUCTIONUsing transformation and transientexpression to introduce new genesinto a host cell. Targeting to the APOPLASM by thetagging with a small peptidesequence.Signal molecules added to target theprotein to the Endoplasmic Reticulum(E.R); to ensures correct folding of theprotein.Higher protein levels obtained in theE.R and the apoplasm as compared tothe cytosol.
  • 6. TRANSFORMATION TARGETING APOPLASM
  • 7. GLYCOSYLATIONGlycosylation refers to theenzymatic process that attachesglycans to proteins, lipids, or otherorganic molecules.It occurs in all higher eukaryotes inthe golgi complex.Glycans serve a variety of structuraland functional roles in membraneand secreted proteins.Glycosylation by plants differs tothat found in mammalian cells.Plant glycans are smaller and havedifferent terminal sugar residues.It is thought this may have animmunogenic effect and have lowantigen-binding affinity.
  • 8. PURIFICATION OF PLANTIBODIES Plantibodies can be purified cheaply in large quantities. Transgenic seeds assure excellent storage properties and due to limited range of endogenous proteins in seeds, separation of plantibody is less complicated. There is no risk of spreading animal diseases to humans as the antibodies are produced by plants The production of large amounts of clinically viable protein especially IgA has many applications in medicine.
  • 9. Techniques for purification of Plantibodies Filtration Immunofluoresence Chromatography Diafiltration Polymer fusionEvaluation techniques for thePlantibodies RIA(Radioimmunoassay) Northern blot analysis ELISA (Enzyme linked immuno- sorbent assay) Western blot analysis Immunofluorescence Southern blot analysis
  • 10. Protection against NematodesNematodes cause huge cropdamage.Plants engineered to expressScFv’s against nematodecellulases have been shown toinactivate the pests.This technology could eradicatethe need for toxic nematicidesand fumigants that arecurrently in use.
  • 11. CONCLUSION Plants provide a cheap, efficient and safe system for the production of antibodies. The progression of transgenic plant technology now has allowed for the progression of human life and other medicinal advancements. It is projected that in the near future, many of the necessary human antibodies will have an origin as a plantibody.
  • 12. REFERENCESLarrick J.W., Yu L., Chen J., et. al.Production of antibodies intransgenic plants.Res. in Immuno. 1998; 149: 603-8.ENCYLOPEDIA OF APPLIED PLANT SCIENCES – Volume 1 A.Edited by – Thomas, Murphy, MurrayPLANT BIOTECHNOLOGY- JOURNAL 6(4) 623-631Mason H.S., Arntzen C.J. Transgenic plants as vaccineproduction systems. Trends in Biotechnology. 1995; 13: 388-92.Schillberg S., Zimmermann S., Zhang M.Y.,Fischer R. Antibody-based resistance to plant pathogens. Transgenic Res. 2001;10:1-12.De Jaeger G., De Wilde C., Eeckhout D.,Fiers E., Depicker A.The plantibody approach:expression of antibody genes inplants to modulate plant metabolism or to obtain pathogenresistance. Plant Mol. Biol. 2000; 43;419-428.

×